ADHD with Comorbid Bipolar Disorders: A Systematic Review of Neurobiological, Clinical and Pharmacological Aspects Across the Lifespan
- PMID: 31385763
- DOI: 10.2174/0929867326666190805153610
ADHD with Comorbid Bipolar Disorders: A Systematic Review of Neurobiological, Clinical and Pharmacological Aspects Across the Lifespan
Abstract
Background: Attention deficit hyperactivity (ADHD) disorder is a neurodevelopmental disorder characterized by inattention, hyperactivity, disruptive behaviour, and impulsivity. Despite considered typical of children for a long time, the persistence of ADHD symptoms in adulthood gained increasing interest during the last decades. Indeed, its diagnosis, albeit controversial, is rarely carried out even because ADHD is often comorbid with several other psychiatric diosrders, in particular with bipolar disorders (BDs), a condition that complicates the clinical picture, assessment and treatment.
Aims: The aim of this paper was to systematically review the scientific literature on the neurobiological, clinical features and current pharmacological management of ADHD comorbid with BDs across the entire lifespan, with a major focus on the adulthood.
Discussion: The pharmacology of ADHD-BD in adults is still empirical and influenced by the individual experience of the clinicians. Stimulants are endowed of a prompt efficacy and safety, whilst non-stimulants are useful when a substance abuse history is detected, although they require some weeks in order to be fully effective. In any case, an in-depth diagnostic and clinical evaluation of the single individual is mandatory.
Conclusion: The comorbidity of ADHD with BD is still a controversial matter, as it is the notion of adult ADHD as a distinct nosological category. Indeed, some findings highlighted the presence of common neurobiological mechanisms and overlapping clinical features, although disagreement does exist. In any case, while expecting to disentangle this crucial question, a correct management of this comorbidity is essential, which requires the co-administration of mood stabilizers. Further controlled clinical studies in large samples of adult ADHD-BD patients appear extremely urgent in order to better define possible therapeutic guidelines, as well as alternative approaches for this potentially invalidating condition.
Keywords: ADHD; bipolar disorders; comorbidity; neurobiology; pharmacological treatments; stimulants..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder.Expert Opin Pharmacother. 2015;16(14):2193-204. doi: 10.1517/14656566.2015.1079620. Expert Opin Pharmacother. 2015. PMID: 26364896 Review.
-
Lifetime evolution of ADHD treatment.J Neural Transm (Vienna). 2021 Jul;128(7):1085-1098. doi: 10.1007/s00702-021-02336-w. Epub 2021 May 15. J Neural Transm (Vienna). 2021. PMID: 33993352 Review.
-
[Adult ADHD: clinical aspects and therapeutic implications].Riv Psichiatr. 2012 Nov-Dec;47(6):451-64. doi: 10.1708/1178.13052. Riv Psichiatr. 2012. PMID: 23160106 Review. Italian.
-
Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD).Expert Opin Pharmacother. 2019 Aug;20(12):1457-1470. doi: 10.1080/14656566.2019.1618270. Epub 2019 May 21. Expert Opin Pharmacother. 2019. PMID: 31112441 Review.
-
Differential diagnosis, comorbidity, and treatment of attention-deficit/hyperactivity disorder in relation to bipolar disorder or borderline personality disorder in adults.Curr Med Res Opin. 2014 Aug;30(8):1657-72. doi: 10.1185/03007995.2014.915800. Epub 2014 May 7. Curr Med Res Opin. 2014. PMID: 24804976 Review.
Cited by
-
Effectiveness of clozapine, oxcarbazepine and rivastigmine combination in a bipolar disorder patient with initial cerebral atrophy.Clin Case Rep. 2020 Jan 7;8(2):254-257. doi: 10.1002/ccr3.2462. eCollection 2020 Feb. Clin Case Rep. 2020. PMID: 32128167 Free PMC article.
-
The Use of Novel Stimulants in ADHD Self-Medication: A Mixed Methods Analysis.Brain Sci. 2025 Mar 10;15(3):292. doi: 10.3390/brainsci15030292. Brain Sci. 2025. PMID: 40149813 Free PMC article.
-
Neuroenhancement: State of the Art and Future Perspectives.Clin Neuropsychiatry. 2021 Jun;18(3):137-169. doi: 10.36131/cnfioritieditore20210303. Clin Neuropsychiatry. 2021. PMID: 34909030 Free PMC article.
-
Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study.Front Psychiatry. 2023 Jul 11;14:1184023. doi: 10.3389/fpsyt.2023.1184023. eCollection 2023. Front Psychiatry. 2023. PMID: 37496681 Free PMC article.
-
Attention-Deficit Hyperactivity Disorder and Comorbid Mental Health Conditions Associated with Increased Risk of Injury.Psychiatry J. 2022 Oct 14;2022:2470973. doi: 10.1155/2022/2470973. eCollection 2022. Psychiatry J. 2022. PMID: 36277995 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical